InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by MOCH KENNETH I, Director. Director active across 1 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 3 reports have been published. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
023,109 shares0
Common Stock
SEC:0001062993-22-015039:0·
05,000 shares0
Common Stock
SEC:0001192482-21-000642·
05,000 shares0
Common Stock
SEC:0001192482-21-000642:0·
3 of 3 declarations
About MOCH KENNETH I
Kenneth I. Moch serves as a Director of Zynerba Pharmaceuticals, Inc. He provides strategic expertise to the board of directors, contributing to governance and key decision-making for the company. His experience in the pharmaceutical sector is an asset to the organization.
